Grants and Contracts Details
| Status | Active |
|---|---|
| Effective start/end date | 5/9/22 → 2/14/25 |
Funding
- Premier Research International LLC: $112,358.00
A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, 76-Week Study Evaluating The Safety And Efficacy Of Two Doses Of Simufilam In Subjects With Mild-To-Moderate Alzheimer's Disease
- Jicha, Gregory (PI)